Search
for

    Sort by

    Research 871–900 of 1000+

    1. Circadian clocks: from stem cells to tissue homeostasis and regeneration EMBO Reports · 2017 · 84 citations
    2. Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms Inflammation Research · 2020 · 82 citations
    3. Neurosteroids, neuroactive steroids, and symptoms of affective disorders Pharmacology, Biochemistry and Behavior · 2006 · 82 citations
    4. A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia Journal of The American Academy of Dermatology · 2011 · 81 citations
    5. Elastic tissue in scars and alopecia Journal of cutaneous pathology · 2000 · 80 citations
    6. Applications of platelet-rich plasma in dermatology: A critical appraisal of the literature Journal of Dermatological Treatment · 2015 · 79 citations
    7. Genome-wide association study identifies a new locus JMJD1C at 10q21 that may influence serum androgen levels in men 2012 · 78 citations
    8. Revisiting dandruff International Journal of Cosmetic Science · 2006 · 78 citations
    9. Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study Annals of Oncology · 2004 · 78 citations
    10. Clinical and biological impact of the exposome on the skin Journal of the European Academy of Dermatology and Venereology · 2020 · 77 citations
    11. The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm Advances in Therapy · 2017 · 77 citations
    12. Clinical Aspects and Spectrum of Illness of TSS: Overview Clinical Infectious Diseases · 1989 · 77 citations
    13. YAP and TAZ are essential for basal and squamous cell carcinoma initiation EMBO Reports · 2018 · 76 citations
    14. Central hair loss in African American women: Incidence and potential risk factors Journal of The American Academy of Dermatology · 2010 · 76 citations
    15. Skin ageing Menopause International · 2007 · 76 citations
    16. Dermatologic Manifestations of Polycystic Ovary Syndrome American Journal of Clinical Dermatology · 2007 · 76 citations
    17. The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression Korean Journal of Urology · 2014 · 75 citations
    18. Template for Skin Regeneration Plastic and Reconstructive Surgery · 2011 · 75 citations
    19. Infertility in Polycystic Ovary Syndrome: Focus on Low-Dose Gonadotropin Treatment Endocrine journal · 2006 · 74 citations
    20. Cutaneous lupus erythematosus Seminars in Cutaneous Medicine and Surgery · 2001 · 74 citations
    21. Safety of dermatologic medications in pregnancy and lactation Journal of The American Academy of Dermatology · 2014 · 73 citations
    22. Ovarian Morphology Is a Marker of Heritable Biochemical Traits in Sisters with Polycystic Ovaries The Journal of Clinical Endocrinology and Metabolism · 2008 · 73 citations
    23. Niosomes as a propitious carrier for topical drug delivery Expert Opinion on Drug Delivery · 2012 · 72 citations
    24. Regeneration of skin appendages and nerves: current status and further challenges Journal of Translational Medicine · 2020 · 71 citations
    25. mTOR signaling promotes stem cell activation via counterbalancing BMP-mediated suppression during hair regeneration 2015 · 71 citations
    26. Insulin Resistance and Skin Diseases The Scientific World Journal · 2015 · 71 citations
    27. The Effect of Plasma Rich in Growth Factors on Pattern Hair Loss: A Pilot Study Dermatologic Surgery · 2017 · 70 citations
    28. Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors Human Reproduction · 2012 · 70 citations
    29. Next generation human skin constructs as advanced tools for drug development Experimental Biology and Medicine · 2017 · 69 citations
    30. Mechanisms of Disease: selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome Nature Clinical Practice Endocrinology & Metabolism · 2005 · 69 citations